| abstract |
An ophthalmic composition capable of improving various symptoms of the eye is provided. (A) At least one selected from vitamin A is 40,000 to 200,000 IU / 100 mL, (B) at least one selected from the group consisting of butylhydroxyanisole and a salt thereof, and (C ) An ophthalmic composition comprising at least one component selected from the group consisting of a decongestant, an eye muscle regulator, an anti-inflammatory agent, a vitamin agent, amino acids and a thickener. [Selection figure] None |